Shin Kawamata studied physics at Faculty of Science of Kyoto University, Japan (1975-1981) and medicine at medical school of Kobe University, Japan (1984-1990). He started his carrier as a medical doctor (hematology) and got PhD degree from Kyoto University (1998). He developed various human leukemia models in SCID mice in his post doctoral period at Systemix Co., Palo Alto USA and Stanford University (1999-2001). Shin became the group leader of Regenerative Medicine Research Unit and the general manager of Cell Processing Facility in the Foundation for Biomedical Research and Innovation (FBRI) (2002-2014) and Director of R&D Center for Cell Therapy (2015-present). His major research fields are cell biology of Pluripotent Stem Cell and hematopoietic cell differentiation.